Category Archives: Patently BIOtech

IP Counsels Committee Conference in Phoenix Discusses Patent Reform

At the latest IP Counsels Committee Conference this past March, Q. Todd Dickinson, Executive Director of the American Intellectual Property Law Association (AIPLA), and E. Anthony Figg of Rothwell, Figg, Ernst & Manbeck, P.C., spoke to BIO’s member companies, universities, and law firm members about patent reform legislation. Patent Docs‘ Donald Zuhn wrote about Dickinson and Figg on Patent Reform yesterday: In the three weeks since the panel session took place, Senate Judiciary Committee Chairman Patrick Leahy Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Federal Trade Commission holds “Evolving IP Marketplace” hearing on Friday, April 17, 2009

The Federal Trade Commission (FTC) is hosting another meeting in a series entitled “The Evolving IP Marketplace.”

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

The Blunders of In Re Kubin

A recent U.S. Federal Circuit of Appeals decision (In Re Kubin) distorts the definition of a patentable invention, threatening the future of biotechnology innovation in the United States. Read our summary.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO IP News Weekly for March 20, 2009

BIO’s weekly newsletter of stories compiled from a variety of public news sources, previously only available to BIO members, is now publicly available: See our temporary version here to check out the news we’re following for March 20, 2009.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

US Court of Appeals for the Federal Circuit Issues Decision in Tafas v Dudas

Read the Decision here: http://tinyurl.com/ce6o7r Read BIO’s Comments to the US Patent and Trademark Office on Proposed Rule Changes Concerning Claims Containing Alternative Language: http://www.bio.org/ip/domestic/20071009.pdf

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,